Live Breaking News & Updates on Michael Amoroso

Stay updated with breaking news from Michael amoroso. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency

Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE's Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Michael Amoroso , Jamesm Wilson , University Of Pennsylvania Gene Therapy Program , Drug Administration , European Commission , Precision Biosciences Inc , Precision Biosciences , Fast Track , Ornithine Transcarbamylase , Rare Pediatric Disease , Orphan Drug , Chief Executive Officer , Gene Therapy Program , Private Securities Litigation Reform Act , Annual Report ,

Precision BioSciences (NASDAQ:DTIL) Given Buy Rating at HC Wainwright

HC Wainwright reissued their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a research note published on Wednesday morning, Benzinga reports. They currently have a $60.00 target price on the stock. Precision BioSciences Stock Down 9.1 % Shares of NASDAQ:DTIL opened at $9.74 on Wednesday. The stock has a market cap […] ....

United States , Michael Amoroso , Blue Owl Capital Holdings , Precision Biosciences Inc , Barclays Plc , Vanguard Group Inc , Goldman Sachs Group Inc , Corient Private Wealth , Precision Biosciences , Free Report , Biosciences Stock Down , Get Free Report , Sachs Group , Owl Capital Holdings , Private Wealth , Precision Biosciences Daily , Nasdaq Dtil , Reiterated Rating , Hc Wainwright ,